| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/19/2009 | WO2009022104A1 Fascaplysin derivatives and their use in the treatment of cancer |
| 02/19/2009 | WO2009021980A1 α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS |
| 02/19/2009 | WO2009021948A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | WO2009021947A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | WO2009021943A2 Novel preparation process |
| 02/19/2009 | WO2009021942A1 Novel preparation process |
| 02/19/2009 | WO2009021758A1 Arylsulfonamides having an analgesic effect |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 02/19/2009 | WO2008157404A3 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 02/19/2009 | WO2008153937A3 Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| 02/19/2009 | WO2008149382A8 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 02/19/2009 | WO2008110891A3 New heterocyclic compounds |
| 02/19/2009 | WO2008008854A8 Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 02/19/2009 | WO2006065484A3 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 02/19/2009 | US20090048449 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | US20090048448 Salts of cynnamide compound or solvates thereof |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048443 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/19/2009 | US20090048308 VLA-4 Antagonists |
| 02/19/2009 | US20090048306 Pyridine derivatives |
| 02/19/2009 | US20090048304 Crystal Form of Besipirdine Chlorhydrate, Process Preparation and Use Thereof |
| 02/19/2009 | US20090048303 Indole-2-carboxamidine derivatives as nmda receptor antago |
| 02/19/2009 | US20090048301 Heterocyclic compounds and their use as anticancer agents |
| 02/19/2009 | US20090048300 Heterocyclic Compounds |
| 02/19/2009 | US20090048299 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/19/2009 | US20090048297 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 02/19/2009 | US20090048291 Novel Piperidine-4-Acetic Acid Derivatives and Their Use |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048269 Chemical compounds-821 |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048263 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048251 4-(1h-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048238 Novel biaryl derivatives |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048223 Sulfonamide compound |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048213 Prodrug of cinnamide compound |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047247 Pyrrolidine Derivatives |
| 02/19/2009 | US20090047238 Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity |
| 02/19/2009 | US20090044345 Use of Metal Complex Compounds as Oxidation Catalysts |
| 02/19/2009 | DE102007038251A1 Neues Herstellverfahren New manufacturing process |
| 02/19/2009 | DE102007038250A1 Neues Herstellverfahren New manufacturing process |
| 02/19/2009 | CA2708320A1 Amide derivatives as trpv1 antagonists |
| 02/19/2009 | CA2696336A1 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696314A1 Therapeutic compounds |
| 02/19/2009 | CA2696257A1 Novel preparation process |
| 02/19/2009 | CA2696205A1 Novel preparation process |
| 02/19/2009 | CA2696012A1 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025675A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols |
| 02/18/2009 | EP2024362A1 Iap bir domain binding compounds |
| 02/18/2009 | EP2024360A2 Substituted pyrazolopyrimidines |
| 02/18/2009 | EP2024359A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's decease and/or schizophrenia |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024356A1 Bicyclic derivatives as cetp inhibitors |
| 02/18/2009 | EP2024355A2 Alkene piperidine derivatives as antiviral agents |
| 02/18/2009 | EP2024354A1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 02/18/2009 | EP2024353A2 Pyrazole compounds |
| 02/18/2009 | EP2024342A2 Substituted 2-amino-fused heterocyclic compounds |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP2023924A2 Aryl-fused spirocyclic compounds |
| 02/18/2009 | EP1928833B1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 02/18/2009 | EP1877396B1 4-(pyridin-3-yl)-2-(pyridin-2-yl)-1,2-dihydro-3h-pyrazol-3-one derivatives as specific hif-prolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases |
| 02/18/2009 | EP1747201B8 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
| 02/18/2009 | EP1732903B1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 02/18/2009 | EP1723143B1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 02/18/2009 | EP1675852B1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 02/18/2009 | EP1641775B1 2-pyridine alkyne derivatives useful for treating pain |
| 02/18/2009 | EP1603886B1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1104405B1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370875A Optical recording medium and azo metal chelate compound |
| 02/18/2009 | CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/18/2009 | CN101370803A Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370802A Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 02/18/2009 | CN101370801A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/18/2009 | CN101370800A Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/18/2009 | CN101370799A Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors |
| 02/18/2009 | CN101370794A Chemical compounds |
| 02/18/2009 | CN101370788A Morpholino pyrimidine derivatives and their use in therapy |